Research & Development



  “衛皇後跟據皇子!”   雲瑯苦笑道︰“我這個永安侯得來的還真是容易啊!”DVD在线播放av视频   霍光嘆口氣道︰“都是一些盲從之輩,在大漢想要找幾個特立獨行之人何其難哉!”迅雷   雲瑯苦笑道︰“我這個永安侯得來的還真是容易啊!”   衛氏听完,眼前金星亂冒,扶住柱子才沒有摔倒,喘息了片刻正要吩咐宮娥傳話給劉據,卻看見劉據氣咻咻的從台階下走了上來。俺来也 為我當繡衣使者的時候沒有享受過?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo